Sign In
Buy VRTX
$428.34
+3.25 (+0.765%)
At Close: Jun 03, 2026
Market Today: Netflix-WBD Deal, X Fined, Meta's News Pacts
05:36pm, Friday, 05'th Dec 2025
Guru Stock PicksJana Partners has made the following transactions:Reduce in MRCY by 16.66%Add in THS by 0.13%Stock News Netflix wins WBD studio deal: Netflix (N
1 Reason I'll Never Sell Vertex Pharmaceuticals Stock
03:10pm, Thursday, 04'th Dec 2025
Vertex Pharmaceuticals dominates the cystic fibrosis treatment market and recently has expanded into other therapeutic areas. The biotech predicts full-year 2025 revenue of as much as $12 billion.
Groupe la Francaise Raises Holdings in Vertex Pharmaceuticals Incorporated $VRTX
05:14am, Thursday, 04'th Dec 2025
Groupe la Francaise boosted its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 25.5% in the second quarter, according to the company in its most recent Form 13F filing with t
Fisher Asset Management LLC Has $11.47 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX
04:40am, Thursday, 04'th Dec 2025
Fisher Asset Management LLC cut its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 16.0% in the undefined quarter, according to its most recent Form 13F filing with the SEC.
Why Is Vertex (VRTX) Up 2.7% Since Last Earnings Report?
12:36pm, Wednesday, 03'rd Dec 2025
Vertex (VRTX) reported earnings 30 days ago. What's next for the stock?
Vertex Pharmaceuticals Incorporated (VRTX) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
11:33am, Wednesday, 03'rd Dec 2025
Vertex Pharmaceuticals Incorporated (VRTX) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Vertex Up 9.2% in 3 Months: Should You Buy, Sell or Hold the Stock?
10:06am, Wednesday, 03'rd Dec 2025
VRTX rises 9.2% in three months but trails its industry as mixed new-drug sales and tightened 2025 guidance cloud near-term momentum.
2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term
06:15am, Wednesday, 03'rd Dec 2025
Alphabet's advertising, cloud, and AI businesses are booming. Vertex is branching out beyond its still-successful core business.
3 Top Stocks to Buy in December
07:45pm, Monday, 01'st Dec 2025
MercadoLibre has tremendous potential in the Latin American e-commerce and fintech markets. TransMedics Group is preparing to expand into Italy and has plenty of room to grow in the U.S. as well.
Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock
10:01am, Monday, 01'st Dec 2025
Zacks.com users have recently been watching Vertex (VRTX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
BLI Banque de Luxembourg Investments Purchases Shares of 6,500 Vertex Pharmaceuticals Incorporated $VRTX
03:28am, Monday, 01'st Dec 2025
BLI Banque de Luxembourg Investments acquired a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) in the second quarter, according to its most recent 13F filing with the Sec
Where Will Vertex Pharmaceuticals Be in 5 Years
06:31am, Thursday, 27'th Nov 2025
Some things will remain the same for Vertex five years from now, including its dominance in treating cystic fibrosis (CF). However, the company will likely achieve success in several new markets beyon
AXQ Capital LP Purchases Shares of 484 Vertex Pharmaceuticals Incorporated $VRTX
04:32am, Wednesday, 26'th Nov 2025
AXQ Capital LP acquired a new position in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) during the undefined quarter, according to the company in its most recent filing with the Securities and Ex
Advisors Asset Management Inc. Has $11.17 Million Holdings in Vertex Pharmaceuticals Incorporated $VRTX
04:12am, Tuesday, 25'th Nov 2025
Advisors Asset Management Inc. reduced its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 9.6% during the undefined quarter, according to its most recent Form 13F filing with
Bank Julius Baer & Co. Ltd Zurich Has $148,000 Position in Vertex Pharmaceuticals Incorporated $VRTX
03:36am, Tuesday, 25'th Nov 2025
Bank Julius Baer and Co. Ltd Zurich cut its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 8.5% in the second quarter, according to its most recent Form 13F filing with the Securiti
